RT @doctorRBC: No significant difference in enthesitis activity in PsA pts taking csDMARD vs. TNFi vs. IL-17i âï¸Age,
Tweet Content
No significant difference in enthesitis activity in PsA pts taking csDMARD vs. TNFi vs. IL-17i
⭐️Age, duration of disease, physician global were main differences in TNFi and IL-17i vs. cDMARD
⭐️no specific clustering noted
Abs#1782
#ACR21 @RheumNow
https://t.co/AH33ZjHUa1 https://t.co/Gb2zKMBUqo
Links
Show on Archive Page
On
Display in Search Results
On
PDQ
Off